Linked Life Data

18652772

Source:http://linkedlifedata.com/resource/pubmed/id/18652772

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-7-25
pubmed:abstractText
The effectiveness and cost-utility of nasal continuous positive airway pressure (nCPAP) treatment was evaluated in obstructive sleep apnoea syndrome (OSAS), using a 15D health-related quality of life (HRQoL) instrument in a routine clinical setting. In total, 78 OSAS patients (43 receiving nCPAP; 35 receiving lifestyle guidance) were included in the study. nCPAP treatment had a minor effect on the total HRQoL score; only the dimension of sleep improved in both groups. The mean +/- SD number of quality-adjusted life years (QALYs) gained was 0.016 +/- 2.34 in the nCPAP group and 0.386 +/- 1.16 in the lifestyle guidance group. The mean cost per QALY gained was euro73 375 for the nCPAP group and euro845 for the lifestyle guidance group. The effect of nCPAP treatment on the HRQoL in a population of unselected OSAS patients was surprisingly small and the cost per QALY gained was high.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0300-0605
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
760-70
pubmed:meshHeading
pubmed:articleTitle
Effect of nasal continuous positive airway pressure therapy on health-related quality of life in sleep apnoea patients treated in the routine clinical setting of a university hospital.
pubmed:affiliation
Department of Pulmonary Medicine, Jorvi Hospital, Helsinki University Central Hospital, Espoo, Finland. jukka.lojander@kolumbus.fi
pubmed:publicationType
Journal Article